Brief: China Nt Pharma Posts FY Loss Attributable Rmb542,000
31/03/2022 16:24
March 31 (Reuters) - China NT Pharma:
* FY LOSS ATTRIBUTABLE RMB542,000 VERSUS LOSS OF RMB357.6
MILLION
* FY REVENUE RMB226.7 MILLION VERSUS RMB221.7 MILLION
Source text for Eikon: ID:nHKSbQKLZp
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million